KATHRYN CUNNINGHAM: Open Payments
NPI 1114953189 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 14 payments from 7 companies in 2025. Trend: 2023 $221 · 2024 $713 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Novo Nordisk Inc | 3 | $61 |
| ABBVIE INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $31 |
| Exact Sciences Corporation | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| PFIZER INC. | 1 | $15 |
Products named: AIRSUPRA, UBRELVY, Ozempic, MOUNJARO, Cologuard Collection Kit, FARXIGA, Rybelsus, SHINGRIX.
Industry payments across PA — which companies pay providers there.
